REX American Resources (REX)
(Delayed Data from NYSE)
$57.04 USD
+0.82 (1.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $57.01 -0.03 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Income Statements
Fiscal Year end for REX American Resources Corporation falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 833 | 855 | 775 | 373 | 418 |
Cost Of Goods | 735 | 800 | 677 | 359 | 406 |
Gross Profit | 98 | 55 | 98 | 14 | 12 |
Selling & Adminstrative & Depr. & Amort Expenses | 29 | 29 | 28 | 18 | 19 |
Income After Depreciation & Amortization | 69 | 26 | 69 | -4 | -7 |
Non-Operating Income | 30 | 22 | 7 | 2 | 6 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 98 | 47 | 76 | -1 | -1 |
Income Taxes | 23 | 10 | 19 | -7 | -13 |
Minority Interest | 15 | 10 | 9 | 3 | 4 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 76 | 38 | 57 | 6 | 12 |
Extras & Discontinued Operations | 0 | 0 | 5 | 0 | 0 |
Net Income (GAAP) | 61 | 28 | 52 | 3 | 7 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 92 | 49 | 93 | 22 | 23 |
Depreciation & Amortization (Cash Flow) | 23 | 23 | 24 | 26 | 29 |
Income After Depreciation & Amortization | 69 | 26 | 69 | -4 | -7 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 17.58 | 17.64 | 17.95 | 18.50 | 18.95 |
Diluted EPS Before Non-Recurring Items | 3.47 | 1.57 | 2.65 | 0.16 | 0.39 |
Diluted Net EPS (GAAP) | 3.47 | 1.57 | 2.92 | 0.16 | 0.39 |
Fiscal Year end for REX American Resources Corporation falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 187.61 | 221.08 | 211.98 | 212.71 | 200.17 |
Cost Of Goods | 162.07 | 181.79 | 193.63 | 197.69 | 185.27 |
Gross Profit | 25.55 | 39.29 | 18.35 | 15.03 | 14.90 |
SG&A, R&D, and Dept/Amort Expenses | 2.52 | 7.61 | 8.62 | 10.63 | 6.72 |
Income After SG&A, R&D, and Dept/Amort Expenses | 23.03 | 31.68 | 9.73 | 4.40 | 8.18 |
Non-Operating Income | 9.43 | 9.60 | 6.32 | 4.29 | 5.16 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 32.46 | 41.28 | 16.05 | 8.69 | 13.34 |
Income Taxes | 7.16 | 9.64 | 3.77 | 1.99 | 2.17 |
Minority Interest | 4.73 | 5.57 | 3.23 | 1.46 | 3.01 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 25.30 | 31.64 | 12.28 | 6.70 | 11.17 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 20.57 | 26.08 | 9.06 | 5.24 | 8.16 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 17.66 | 17.53 | 17.46 | 17.44 | 17.42 |
Diluted EPS Before Non-Recurring Items | 1.16 | 1.49 | 0.52 | 0.30 | 0.47 |
Diluted Net EPS (GAAP) | 1.16 | 1.49 | 0.52 | 0.30 | 0.47 |